RxDoctor Payments DataLook up a doctor →

James Simon

Gynecology · Washington, DCNPI 1700947256

Payments from drug & device makers

$1,992,743in general payments, 2019–2025

Across 1,175 payments — averaging $1695.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$750K
  • Mayne Pharma Commercial LLC$328K
  • Sumitomo Pharma America, Inc.$250K
  • Bayer$236K
  • Mylan Inc.$107K
  • Therapeuticsmd, Inc.$81K
  • plus $241K from 36 others
$36,653in research payments, 2019–2025

Across 24 payments — averaging $1527.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Myovant Sciences GmbH$33K
  • AbbVie$4K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few gynecology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Other gynecology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →